Just wondering if the phase11B/111 clinical trials can start before FDA approval of the IND status of CVAC.
I assume that this will be the case since PRR are wanting to apply the technology in countries apart from the USA.
Hence according to the description below taken from the announcement on the 30 July re the lodging of the IND application with the FDA,the trials will be beginning SOON meaning perhaps in a number of days rahter than weeks. This event will also attract much interest and help confirm the great potential of the company and its lead product,CVAC.
"Prima is making excellent progress in preparation for CVac™’s US FDA Phase IIb/III
Pivotal Trial, which the Company plans to commence in the near future".
won't be long before next major announcement
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.5¢ | 28.5¢ | $469.8K | 1.579M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 297652 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 7500 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |